Athena, a voice for professional women in STEM in Southern California, recently became a signatory of the United Nations Global Compact. Athena joins over 9,933 companies in 160 countries focused on aligning their strategies and
Orthotopic Patient-Derived Xenografts (PDX) Despite the rise of personalized approaches to the treatment of cancer, translating these therapies into a clinical setting still poses an exceptional challenge. This is highlighted in drug development where research
SAN DIEGO, AUGUST 13, 2018. (GLOBE NEWSWIRE). Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services.
PALO ALTO, Calif.–(BUSINESS WIRE)–Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with Reveal Biosciences to offer on-demand access to AI-based pathology services worldwide. Reveal Biosciences is a San Diego-based company that’s leading the next generation
CASE STUDY Cancer R&D researchers have adopted the use of immunohistochemistry (IHC) tests for research, prognostic and diagnostic use at an extremely fast rate (1). Despite these statistics, many antibody vendors targeting these researchers do
CASE STUDY Researchers have adopted the use of immunohistochemistry (IHC) tests for research, prognostic and diagnostic use at an extremely fast rate (1). There are over 3 million commercially available antibodies; however, in a Nature
Reveal Biosciences utilizes artificial intelligence (A.I.) to develop highly accurate and scalable pathology diagnostic tools which have a significant impact on drug discovery, precision medicine, and clinical trials. Watch this video to learn about Reveal